The JAK3 gene helps immune cells receive signals they need to grow, survive, and fight infections. This gene plays an important role in helping T cells and natural killer cells, two key infection-fighting cell types, develop and work normally. If JAK3 does not work, a person can be born with a form of severe combined immunodeficiency, which leaves the body with very weak immune defenses and repeated infections. Certain other JAK3 variants may also play a role in some blood cancers.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or manage processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly guide when certain processes take place, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
JAK3Gene function
What if the gene works
The JAK3 gene helps immune cells receive growth and survival signals. This supports the development and function of T cells and natural killer cells, and helps B cells work normally.
Risk
What if the gene does not work
More severe variants in the JAK3 gene can cause severe combined immunodeficiency, with very weak defenses against infection from early life. Milder variants may leave some JAK3 activity, so immune problems can appear later or be less pronounced.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the JAK3 gene usually point to immune reconstitution treatment, most often hematopoietic stem cell transplantation. Until that is done, care commonly includes immunoglobulin replacement, infection prevention, and avoiding live vaccines. No targeted medicine is currently established for JAK3 loss of function.
Conditions associated with JAK3
Gene function
What if the gene works
The JAK3 gene helps white blood cells respond to growth and communication signals. It is most active in lymphocytes, the immune cells that help your body recognize and handle infections. This steady signaling helps immune cells grow, stay alive, and work together.
A key part of what the JAK3 gene does is pass immune messages from the cell surface to the cell’s inner control systems. It is switched on when certain messenger proteins bind to receptors on white blood cells.
JAK3 works with a receptor part called the common gamma chain (a shared docking piece on several immune receptors). This lets several immune messenger proteins use the same communication route.
These JAK3 signals help T cells, B cells, and natural killer cells grow, mature, and stay active. They also help immune cells coordinate their responses once a message has been received.
After a signal arrives, JAK3 helps turn on STAT proteins (message carriers inside the cell). These proteins carry instructions to the nucleus so the cell can use the right genes at the right time.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal differences between people, such as appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the JAK3 gene can change the shape, stability, or signaling activity of the JAK3 protein, which helps explain how JAK3 gene variants affect protein activity in immune cells. Milder variants may leave some signaling intact, while more severe variants can sharply reduce or stop signaling, often linking to earlier or more marked immune problems. A smaller number of variants can increase signaling instead of reducing it, which also disrupts how cells respond and grow.
How variants are linked to conditions
Variants in the JAK3 gene can cause a form of severe combined immunodeficiency, or SCID, that leaves babies with limited immune defenses and repeated infections. This JAK3 gene severe combined immunodeficiency is usually inherited when both copies of the gene carry pathogenic variants. Some acquired, non-inherited JAK3 variants are also found in certain blood cancers.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For JAK3, risk is mostly shaped by the gene changes you inherit, not by lifestyle. A child’s chance is higher when both parents carry a harmful JAK3 change, and it can also be higher in families where relatives have children together. Once a disease-causing JAK3 change is present, daily habits do not meaningfully change whether the condition develops.
Inheritance of JAK3 variants
For inherited conditions linked to the JAK3 gene, the best established pattern is autosomal recessive inheritance. This means a child inherits two disease causing variants in the JAK3 gene, one from each parent, and the parents are usually healthy carriers. When both parents carry one variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with neither variant. In practical terms, JAK3 gene inheritance usually matters most in families affected by a recessive immune condition such as severe combined immunodeficiency.
What does my JAK3 result mean for my family?
For inherited JAK3-related immune conditions, family members can sometimes carry the same gene change even if they feel well. Parents of an affected child are often carriers, and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same JAK3 change is present in the family, especially when there is a history of serious early-life infections.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for JAK3 variants usually uses a blood sample or cheek swab. A lab reads the DNA in the JAK3 gene and reports whether a variant is found, including whether it is known to cause disease, likely harmless, or still uncertain. These results can help clarify an inherited immune condition.
When should I consider getting a genetic test?
If a baby or child has severe, repeated infections, poor growth, or a newborn screen suggesting a serious immune problem, testing the JAK3 gene may help find the cause. It can also be worth considering when there is a family history of severe combined immunodeficiency, especially in siblings.
A genetic result is only one part of your health story
Genetic test findings can offer useful insight, although how much they reveal depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way a person responds to medication. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, you can read more in the LearnHub.
Drugs influenced by the JAK3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about side effects, treatment response, or new symptoms are best discussed with your doctor. JAK3 has been studied in research on some immune and cancer medicines, especially drugs that act on the same signaling pathway, but this is not yet standard prescribing guidance.
History
The JAK3 gene entered medical genetics in the 1990s, when researchers identified it as part of the newly described Janus kinase family. In recent decades, awareness of this gene’s role has grown as studies linked inherited variants in the JAK3 gene to a form of severe combined immunodeficiency, a condition where the immune system does not develop normally. This discovery helped explain why some infants had repeated, hard to control infections from very early life. Building on this early work, scientists uncovered more about the JAK3 gene through immune research and later through interest in medicines that target JAK pathways. Over time, descriptions became more precise. Today, the JAK3 gene is recognized as an important part of the history of modern immune genetics.